Banner Health, Cerner alliance to focus on population health

Banner Health and Cerner have launched a multi-year strategic partnership to advance and innovate care delivery through developments in health IT and population health management.

This collaboration between the Phoenix, Ariz.-headquartered health system and EHR vendor builds upon a past relationship that includes the deployment of the Cerner Millenium EHR across 26 Banners. Twenty-one of those hospitals have been recognized as HIMSS EMRAM Stage 7 organizations.

Banner Health and Cerner will continue to roll out Cerner Millennium across all of Banner’s campuses and clinics, which will include a comprehensive strategy to align the provider’s clinic-based record with the hospital’s acute care record, according to a release. The two organizations will further collaborate to manage entire populations and improve clinical outcomes, with the roll out and adoption of several Cerner HealtheIntent ℠ enabled solutions across the organization. This platform is designed to aggregate the clinical, financial and operational data that occurs as part of care delivery and then normalize the data to allow for deeper insights and interventions for both individuals and entire populations.

“At Banner we’re convinced that the transformation of health care--better outcomes and enhanced services for less costs--will largely occur through population health management plans that improve usage and management of services in hospitals and clinics,” said Peter S. Fine, Banner Health president and CEO. “Effective and innovative electronic solutions will be at the heart of this transformation, and Cerner is an ideal partner as a leading organization in these efforts.”

As part of the commitment, key Cerner leaders and associates will relocate and be permanently assigned to Banner’s headquarters in Phoenix. The Cerner team will closely engage with Banner colleagues to ensure the successful implementation and adoption of health IT solutions, while also fostering new ideas and innovation around future development. This partnership will include the development and opening of an on-site conference and visitor center that will test and showcase these innovations and their impact on health management resources.  

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.